The Journal of Pediatrics
Volume 141, Issue 4 , Pages 566-571, October 2002

Clinical findings leading to the diagnosis of X-linked agammaglobulinemia☆☆

Department of Immunology, St Jude Children's Research Hospital, and the Department of Pediatrics, University of Tennessee College of Medicine, Memphis, Tennesee

Received 23 January 2002; received in revised form 6 May 2002; accepted 19 June 2002.

Abstract 

To evaluate whether the diagnosis of X-linked agammaglobulinemia (XLA) is being made in a timely fashion, the clinical findings leading to the diagnosis of XLA were determined in 82 patients with proven mutations in Bruton's tyrosine kinase (60 patients with sporadic disease and 22 patients with familial disease). Recurrent otitis was seen in almost all of the patients with sporadic XLA who were older than 12 months at the time of diagnosis. However, fewer than 10% of patients were evaluated for immunodeficiency before they were hospitalized for infection; 38% of patients were hospitalized more than once before diagnosis. We conclude that the majority of patients with XLA were recognized to have immunodeficiency during or shortly after their first hospitalization for infection. Most of the patients had a history of recurrent otitis at the time of diagnosis, which when combined with the physical finding of markedly decreased or absent tonsils and cervical lymph nodes, could have alerted physicians to the diagnosis of XLA. (J Pediatr 2002;141:566-71)

Abbreviations:  Btk , Bruton's tyrosine kinase, Ig , Immunoglobulin, XLA , X-linked agammaglobulinemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from the National Institutes of Health AI25129, National Cancer Institute grant P30 CA21765, the Assisi Foundation, March of Dimes, American Lebanese–Syrian Associated Charities, and the Federal Express Chair of Excellence.

☆☆ Reprint requests: Mary Ellen Conley, MD, University of Tennessee College of Medicine, St Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105.

PII: S0022-3476(02)00143-9

doi:10.1067/mpd.2002.127711

The Journal of Pediatrics
Volume 141, Issue 4 , Pages 566-571, October 2002